NL180589C - Verbindingen met anti-microbiele werking uit de beta-lactamreeks en farmaceutische preparaten die een dergelijke verbinding als werkzame stof bevatten. - Google Patents
Verbindingen met anti-microbiele werking uit de beta-lactamreeks en farmaceutische preparaten die een dergelijke verbinding als werkzame stof bevatten.Info
- Publication number
- NL180589C NL180589C NLAANVRAGE7902906,A NL7902906A NL180589C NL 180589 C NL180589 C NL 180589C NL 7902906 A NL7902906 A NL 7902906A NL 180589 C NL180589 C NL 180589C
- Authority
- NL
- Netherlands
- Prior art keywords
- beta
- compounds
- compound
- active substance
- pharmaceutical preparations
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
- C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Cephalosporin Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP53043624A JPS6034957B2 (ja) | 1978-04-12 | 1978-04-12 | ペニシラン酸誘導体 |
JP53110464A JPS6037118B2 (ja) | 1978-09-07 | 1978-09-07 | ペニシラン酸誘導体 |
JP53141785A JPS6037119B2 (ja) | 1978-11-16 | 1978-11-16 | ペニシラン酸誘導体 |
JP53145638A JPS5951959B2 (ja) | 1978-11-24 | 1978-11-24 | ペニシラン酸誘導体 |
Publications (3)
Publication Number | Publication Date |
---|---|
NL7902906A NL7902906A (nl) | 1979-10-16 |
NL180589B NL180589B (nl) | 1986-10-16 |
NL180589C true NL180589C (nl) | 1987-03-16 |
Family
ID=27461393
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NLAANVRAGE7902906,A NL180589C (nl) | 1978-04-12 | 1979-04-12 | Verbindingen met anti-microbiele werking uit de beta-lactamreeks en farmaceutische preparaten die een dergelijke verbinding als werkzame stof bevatten. |
Country Status (18)
Country | Link |
---|---|
US (1) | US4317820A (xx) |
AR (2) | AR227005A1 (xx) |
AT (1) | AT368159B (xx) |
AU (1) | AU524795B2 (xx) |
CA (1) | CA1133469A (xx) |
CH (1) | CH642081A5 (xx) |
DE (1) | DE2914218C2 (xx) |
DK (1) | DK149479A (xx) |
ES (2) | ES480281A1 (xx) |
FI (1) | FI70219C (xx) |
FR (1) | FR2422666A1 (xx) |
IT (1) | IT1162605B (xx) |
MX (1) | MX5704E (xx) |
NL (1) | NL180589C (xx) |
NO (2) | NO791223L (xx) |
PT (1) | PT69473A (xx) |
SE (1) | SE7903297L (xx) |
SU (1) | SU1151212A3 (xx) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5792774A (en) * | 1996-02-21 | 1998-08-11 | Chiroscience Limited | Quinolones and their therapeutic use |
US6525049B2 (en) | 2000-07-05 | 2003-02-25 | Pharmacia & Upjohn Company | Pyrroloquinolones as antiviral agents |
PL1954697T3 (pl) * | 2005-10-21 | 2010-07-30 | Glaxo Group Ltd | Peri skondensowane tricykliczne związki użyteczne jako środki przeciwbakteryjne |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL175419C (nl) * | 1971-10-23 | 1984-11-01 | Bayer Ag | Werkwijze ter bereiding of vervaardiging van antibiotisch werkzame farmaceutische preparaten, alsmede werkwijze ter bereiding van antibiotisch werkzame alfa-gesubstitueerde 6-(alfa-(3-acylureido)acetylamino) penicillanzuurderivaten. |
US3780034A (en) * | 1971-11-29 | 1973-12-18 | Merck & Co Inc | Process for preparing substituted cephalosporins |
US3778432A (en) * | 1971-12-13 | 1973-12-11 | Merck & Co Inc | Isocyanates and carbamates of penicillins and 3-cephem-4-carboxylic acids |
BE793524A (fr) | 1971-12-30 | 1973-06-29 | Riker Laboratories Inc | Acides benzoquinolizine-carboxyliques et leurs derives |
US3954731A (en) * | 1972-07-03 | 1976-05-04 | Eli Lilly And Company | Process for preparing 6-alkoxypenicillanic and 7-alkoxycephalosporin acids |
US3917609A (en) | 1973-06-27 | 1975-11-04 | Minnesota Mining & Mfg | Pyrroloquinoline carboxylic acids and derivatives |
US4062842A (en) * | 1973-09-06 | 1977-12-13 | E. R. Squibb & Sons, Inc. | Method for preparing 7-substituted cephalosporins and 6-substituted penicillins by replacement of sulfur-containing groups |
DE2559932C2 (de) | 1974-05-09 | 1983-04-21 | Toyama Chemical Co. Ltd., Tokyo | Cephalosporine, Verfahren zur Herstellung derselben und Mittel mit einem Gehalt derselben |
US3962214A (en) * | 1974-07-11 | 1976-06-08 | Eli Lilly And Company | Process for preparing amino substituted β-lactam antibiotics |
-
1979
- 1979-04-09 DE DE2914218A patent/DE2914218C2/de not_active Expired
- 1979-04-10 IT IT48691/79A patent/IT1162605B/it active
- 1979-04-10 DK DK149479A patent/DK149479A/da not_active Application Discontinuation
- 1979-04-10 US US06/028,770 patent/US4317820A/en not_active Expired - Lifetime
- 1979-04-10 NO NO79791223A patent/NO791223L/no unknown
- 1979-04-11 AU AU46038/79A patent/AU524795B2/en not_active Ceased
- 1979-04-11 AR AR276166A patent/AR227005A1/es active
- 1979-04-11 SU SU792753360A patent/SU1151212A3/ru active
- 1979-04-11 ES ES480281A patent/ES480281A1/es not_active Expired
- 1979-04-11 CH CH343479A patent/CH642081A5/de not_active IP Right Cessation
- 1979-04-11 AT AT0269079A patent/AT368159B/de not_active IP Right Cessation
- 1979-04-11 PT PT69473A patent/PT69473A/pt unknown
- 1979-04-11 FI FI791190A patent/FI70219C/fi not_active IP Right Cessation
- 1979-04-11 MX MX797868U patent/MX5704E/es unknown
- 1979-04-11 CA CA325,375A patent/CA1133469A/en not_active Expired
- 1979-04-12 FR FR7909337A patent/FR2422666A1/fr active Granted
- 1979-04-12 NL NLAANVRAGE7902906,A patent/NL180589C/xx not_active IP Right Cessation
- 1979-04-12 SE SE7903297A patent/SE7903297L/xx unknown
-
1980
- 1980-01-30 ES ES488833A patent/ES488833A0/es active Granted
-
1981
- 1981-03-11 AR AR284582A patent/AR226883A1/es active
-
1984
- 1984-02-20 NO NO84840617A patent/NO840617L/no unknown
Also Published As
Publication number | Publication date |
---|---|
NO791223L (no) | 1979-10-15 |
CA1133469A (en) | 1982-10-12 |
FI70219C (fi) | 1986-09-15 |
AR227005A1 (es) | 1982-09-15 |
DE2914218A1 (de) | 1979-10-25 |
ES8200339A1 (es) | 1981-11-16 |
ATA269079A (de) | 1982-01-15 |
IT1162605B (it) | 1987-04-01 |
ES480281A1 (es) | 1980-08-16 |
FI70219B (fi) | 1986-02-28 |
SU1151212A3 (ru) | 1985-04-15 |
PT69473A (en) | 1979-05-01 |
NO840617L (no) | 1979-10-15 |
ES488833A0 (es) | 1981-11-16 |
NL7902906A (nl) | 1979-10-16 |
NL180589B (nl) | 1986-10-16 |
AU524795B2 (en) | 1982-10-07 |
US4317820A (en) | 1982-03-02 |
SE7903297L (sv) | 1979-12-21 |
FI791190A (fi) | 1979-10-13 |
DK149479A (da) | 1979-10-13 |
FR2422666A1 (fr) | 1979-11-09 |
AU4603879A (en) | 1979-10-18 |
MX5704E (es) | 1983-12-16 |
AT368159B (de) | 1982-09-27 |
DE2914218C2 (de) | 1985-10-24 |
FR2422666B1 (xx) | 1983-02-04 |
AR226883A1 (es) | 1982-08-31 |
IT7948691A0 (it) | 1979-04-10 |
CH642081A5 (de) | 1984-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL7802792A (nl) | Cefem- en cefam-verbindingen met antimicrobiele werking, werkwijzen ter bereiding daarvan, als- mede farmaceutische preparaten die deze verbin- dingen als actieve component bevatten. | |
NL990037I2 (nl) | Een isoxazoolderivaat, werkwijze voor zijn bereiding en deze verbinding bevattende middelen. | |
NL190664C (nl) | Gesubstitueerde benzhydrylpiperidinoderivaten met therapeutische werking en farmaceutische preparaten die deze verbindingen bevatten. | |
NL177749C (nl) | N-(fenoxyalkyl)imidazolen en farmaceutische preparaten die deze verbindingen als werkzame stof bevatten. | |
NL980013I1 (nl) | Gesubstitueerde benzhydrylpiperidinederivaten met therapeutische werking en preparaten die deze stoffen bevatten. | |
NL160150C (nl) | Werkwijze ter bereiding van 3-acyloxy-2-fenyl-1h- -indeen-1-on-derivaten met herbicide- en acaricide werking, alsmede herbicide- en acaricidepreparaten die deze verbindingen als actieve component bevatten. | |
NL7712567A (nl) | Werkwijze ter bereiding van trigesubstitueerde 1-fenyl-2,3,4,5-tetrahydro-1h-3-benzazepine verbindingen, alsmede farmaceutische prepara- ten die deze verbindingen als actieve component bevatten. | |
NL193907B (nl) | Basische ether en farmaceutische samenstelling die de basische ether als actief bestanddeel bevat. | |
NL181004C (nl) | Parfumcomposities alsmede geparfumeerde produkten, welke ten minste een acylpolyalkylindanverbinding als reukstof bevatten, alsook de toegepaste acylpolyalkylindanverbindingen. | |
NL188576C (nl) | Carbamoyloxazolidonderivaten met pesticide werking alsmede acaricide preparaten, die dergelijke verbindingen bevatten. | |
NL192265B (nl) | Penemcarbonzuur-verbindingen en farmaceutische preparaten die deze verbindingen bevatten. | |
NL7702728A (nl) | Farmacologisch actieve stof uit lipbloemigen. | |
NL7613404A (nl) | Werkwijze voor de vermindering van de hoeveel- heid van een biologisch actieve stof onder hand- having van de biologische werking. | |
NL7903650A (nl) | Purinederivaten met bronchi verwijdende werking alsmede farmaceutische preparaten die deze verbinding als ac- tieve component bevatten. | |
NL180664C (nl) | 1,8-alkyleen-3-carboxy-4-oxo-7-piperazinochinolinederivaten, werkwijze voor de bereiding daarvan en anti-microbiele preparaten die een dergelijke verbinding als werkzame stof bevatten. | |
NL7503759A (nl) | Werkwijze voor de bereiding van haloacylanili- den, alsmede daaruit bereide preparaten met een microbicide werking. | |
NL172157C (nl) | Preparaat met bloeddrukverlagende werking en de daarvoor geschikte werkzame verbindingen. | |
NL173750C (nl) | Farmaceutisch preparaat met prostaglandine-antagonistische werking alsmede daarin bruikbare monocyclische organische verbindingen. | |
NL180589C (nl) | Verbindingen met anti-microbiele werking uit de beta-lactamreeks en farmaceutische preparaten die een dergelijke verbinding als werkzame stof bevatten. | |
NL7416784A (nl) | Insecticidemiddel voor ulv-toepassing. | |
NL8002959A (nl) | Hydroxyamino-eburnaanderivaten en een werkwijze voor de bereiding hiervan en de toepassing als farmaceutisch actieve stof. | |
NL7708427A (nl) | Werkwijze ter bereiding van een geneesmiddel met antibiotische werking, gevormd geneesmiddel met antibiotische werking, alsmede werkwijze ter bereiding van geneeskrachtige verbindingen, die als aktieve verbinding in genoemde preparaten kunnen worden gebruikt. | |
NL7508067A (nl) | Pesticideverbindingen en preparaten. | |
NL7416783A (nl) | Insecticidenmiddel voor ulv-toepassing. | |
NL7801128A (nl) | (alpha)-trifluormethyl-3-fenoxybenzylcarboxylaten met insecticide werking, insecticide preparaten die deze verbindingen bevatten, alsmede werk- wijze voor het bestrijden van insecten en acariden met behulp van de verbindingen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1B | A search report has been drawn up | ||
BC | A request for examination has been filed | ||
A85 | Still pending on 85-01-01 | ||
V1 | Lapsed because of non-payment of the annual fee |